Cangrelor tetrasodium

Definition: Cangrelor, sold under the brand name Kengreal among others, is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Some P2Y12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation. Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not requiring metabolic conversion. source: Wikipedia

ID

1217149008

ID date

6 Dec 2022

Previous ID

30192311000001102

Name

Cangrelor tetrasodium